A closer look
Dying is terrifying, but tripping on a clinical dose of psilocybin seems to permanently fix the fear. Groundbreaking research from Johns Hopkins University revealed that a single, guided high-dose psilocybin session induced profound mystical experiences in terminal cancer patients. By temporarily disrupting the brain's Default Mode Network—the region responsible for your sense of 'self' and ego—the psychedelic allows patients to embrace the end of life, dropping depression scores by over 80%.
